Bartjan van Hulten, CFA, executive director, is an analyst in the U.S. Equity Research Group covering the Pharmaceuticals/Biotechnology sector. Prior to joining JP Morgan, Bartjan ran Medex Capital, a global healthcare fund he founded in 2011. Before that, he was at Fidelity Investments as healthcare team leader, covering healthcare investments across a broad range of European and US portfolios. From 1998 to 2003, he led the healthcare research team at MeesPierson (ABNAmro), covering European and US healthcare companies. He began his career at Raytheon in 1996 having completed service as a lieutenant in the Dutch Navy. Bartjan holds a Masters in Business Administration from Insead and a Masters in Science in Applied Physics from Delft University of Technology, the Netherlands. He is also a CFA Charterholder.